InsidersTradesSigma
Follow the 한화생명 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Banks sector, 한화생명 has logged 216 reports. Market capitalisation: €3,328.7bn. The latest transaction was filed on 13 July 2026 (Purchase). Among the most active insiders: 김국진. All data is accessible without an account.
216
Insider Decl.
n/a
Thresholds
€8,932
81 ops.
Buy Volume
n/a
3 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 한화생명 Hold (neutral), based on 13 analysts. Average price target: ₩5,200.
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 13,317 of 29,062 companies
54.2
score / 100
Value72
Quality37
FCF yld·
Earn yld17%
EV/EBITDA11.8x
ROE7.8%
Gross mgn·
Net mgn4.4%
Debt/EBITDA8.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 July 2026
Declarations216 total
3,000 sharesShareKRXDART:20250825000362
25 of 216 declarations
关于 한화생명
Hanwha Life 是一家韩国保险公司，提供各种人寿保险产品和金融服务。该公司在 XKRX 上市。